Opening Remarks – Dr. Noa Efrat (Ben-Baruch)
Standard and Future Approaches in the Management of Neoadjuvant Therapy for HER2-Positive – Prof. Sandra M. Swain
Fundamentals of Neoadjuvant Therapy – Consensus & Controversies in Local Therapy – Prof. Christian Jackisch
Less is More: Minimizing Interventions Debate: Is Surgery Necessary After cCR Following Neoadjuvant Treatment?
Pro: Prof. Dan Hershko
Less is More: Minimizing Interventions Debate: Is Surgery Necessary After cCR Following Neoadjuvant Treatment?
Con: Prof. Moshe Inbar
Practical Considerations and Unresolved Issues in Neoadjuvant Therapy – Q&A – Open Panel Discussion
Modifying HER2-Positive Treatment in Early Breast Cancer-Past, Present and Future – Prof. Christian Jackisch
The Optimal Treatment Sequence for HER2+ Metastatic Breast Cancer – Prof. Sandra M. Swain
Breast Cancer Diagnosed During Pregnancy. Imaging, Surgical and Treatment Recommendations – Dr. Ora Rosengarten
Pregnancy After the Diagnosis of Breast Cancer: Safety Timing and Dilemmas – Dr. Shani Paluch-Shimon
ESR Mutations in Recurrent/Metastatic Breast Cancer Patients – The Sheba Experience - Dr. Einav Nili Gal-Yam
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers – Dr. Ella Evron